News

Mergers Alliance US Healthcare Specialist Publishes Research Report on the Generic Pharmaceuticals Sector
21st May 2009

Brocair Partners LLC, a member of Mergers Alliance in the USA that exclusively serves the healthcare industry, is delighted to announce the publication of its latest research report. The focus of the report is the generic pharmaceuticals market, and is available on Brocair Partners’ website (www.brocair.com).

Brocair Partners LLC, a member of Mergers Alliance in the USA that exclusively serves the healthcare industry, is delighted to announce the publication of its latest research report. The focus of the report is the generic pharmaceuticals market, and is available on Brocair Partners’ website (www.brocair.com).
As the new Administration works to reform healthcare and reduce costs across the system, generics have been highlighted as part of the solution. Generics, in many cases, though selling for a fraction of the price of their branded counterparts, have the ability to offer significant savings to consumers and healthcare providers, alike.
For many years, generics have been a mainstay in the marketplace, accounting for approximately 70% of all prescriptions dispensed. Generic equivalents are available for indications ranging from allergy and respiratory to cardiovascular to gastrointestinal.
In the coming years, as many of today’s “blockbuster” drugs lose patent exclusivity, generics will continue to be an important component in the overall prescription drug market.
The Brocair Partners report contains a matrix of the indications addressed by companies that compete in this sector, an overview of the participants in the industry, short company profiles of selected companies, a market and valuation analysis, and an overview of recent corporate transactions.